BN Business News
Add your company to Business Communicator →

Regulacje i polityka gospodarcza · 27.11.1995

Findings of Scientific Misconduct

Notice is hereby given that the Office of Research Integrity (ORI) has made final findings of scientific misconduct in the following case: Daniel P. Bednarik, Ph.D., Centers for Disease Control and Prevention (CDC): Based on an investigation conducted by the Division of Research Investigations, ORI found that Daniel P. Bednarik, Ph.D., engaged in scientific misconduct by fabricating and falsifying research data in two scientific manuscripts that were submitted for publication to the journal Nucleic Acids Research and to the journal AIDS. One paper, entitled ``Expression of the human (cytosine-5) methyltransferase is regulated by alternative mRNA splicing,'' was not accepted and the other, entitled ``Indirect evidence for an EBV-HIV hybrid virus: Human immunodeficiency virus type 1 and Epstein-Barr virus genome association,'' was withdrawn before review. Dr. Bednarik is a former employee of CDC, and the research was done while he was employed by CDC. Dr. Bednarik and ORI have entered into a Voluntary Exclusion Agreement, which the parties agreed shall not be construed as an admission of liability or wrongdoing on the part of Dr. Bednarik. Dr. Bednarik has agreed not to appeal ORI's

Source: Federal Register — All DocumentsOpen original release →